Biologics

At Juno, our goal is twofold: increase patient access to high quality, lifesaving medicines and increase value within the Australian healthcare system.

Biosimilars and interchangeable biologic products present an opportunity to patients, healthcare professionals and the government, by providing increased patient access to therapies, whilst helping maintain the long-term viability and financial sustainability of the Australian and New Zealand healthcare systems.

We believe that we have the right expertise and strategies to effectively partner with biologic developers whose brands are reaching their patent expiry, plus biosimilar developers with plans to launch in Australia and New Zealand.

Our Pipeline

Juno is focused on partnering with leading biologic and biosimilar manufacturers, to increase patient access to these lifesaving and life changing medicines in Australia and New Zealand.

Read more

Team Behind Juno Biologics

Our team are amongst few specialists nationally with extensive experience with biosimilar medicines.

Read more

News

Keep up to date with the latest business development, product launches and company news from Juno.

Read more

What Is A Biologic?

Learn more about biologic and biosimilar medicines, an area that is at the forefront of modern medical research.

Read more